Optherion
Latest round
- Series A
Last raised
- Oct 2007
Total raised
- $37M
Investors
- 8
About Optherion
Optherion, Inc. is a biotechnology company that is developing diagnostic and disease-modifying therapeutics for the management and treatment of early-stage age-related macular degeneration (AMD).
Who invested in Optherion
8 investors across 2 rounds
See all investors in Optherion
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Optherion
Who invested in Optherion?
Optherion has 8 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Optherion raised?
Optherion has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Optherion last raise money?
Optherion's most recent round on record is a Series A, in Oct 2007.
What does Optherion do?
Optherion is a biotechnology company.
Where is Optherion headquartered?
Optherion is headquartered in New Haven, US.
Which VCs invest in companies like Optherion?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Optherion's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Optherion? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.